Unveiling 6 Analyst Insights On Capricor Therapeutics
Unveiling 6 Analyst Insights On Capricor Therapeutics
揭示了6条关于capricor therapeutics的分析师见解。
Analysts' ratings for Capricor Therapeutics (NASDAQ:CAPR) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
过去一个季度，6位分析师对Capricor Therapeutics (NASDAQ:CAPR)的评级从看好到看淡各不相同。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $27.83, a high estimate of $40.00, and a low estimate of $8.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.45%.
经过分析师的评估，12个月的目标价位提供了有价值的参考意见，平均目标价为27.83美元，最高估计为40.00美元，最低估计为8.00美元。由于分析师将平均目标价下调了8.45％，因此情绪出现了负面的变化。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
In examining...
通过...
登录免费看全文
登录/注册